Normal insulin secretion is 40 to 50 units per day in an adult
Normal glucose level range is 74 to 106 mg/dL
Normal glucose and insulin metabolism
1. Insulin promotes glucose transport into cells
2. Insulin inhibits gluconeogenesis, enhances fat deposition, and increases protein synthesis
3. Insulin-dependent tissues: Skeletal muscle and adipose tissue
4. Non-insulin-dependent tissues: Other tissues still require glucose
Counterregulatory hormones
Glucagon
Epinephrine
Growth hormone
Cortisol
Insulin is synthesized from proinsulin and C-peptide is a useful indicator of beta-cell function and insulin levels
Type 1 diabetes
Accounts for 5% to 10% of all diabetes, generally affects people under age 40, can occur at any age
Type 1 diabetes etiology
Autoimmune disorder where body develops antibodies against insulin and/or pancreatic beta cells, genetic link with HLAs and virus exposure
Onset of type 1 diabetes
1. Islet cell autoantibodies present for months to years before symptoms
2. Rapid onset with ketoacidosis when pancreas can no longer make enough insulin
3. Patient may have temporary remission after starting treatment
Type 2 diabetes
Most prevalent type (90% to 95%), many risk factors including overweight/obesity, advanced age, family history, greater prevalence in ethnic groups
Type 2 diabetes etiology
Pancreas usually makes some endogenous insulin but not enough is produced and/or body does not use insulin effectively, genetic link with multiple genes and metabolic abnormalities
Onset of type 2 diabetes
Gradual onset, person may go many years with undetected hyperglycemia, often discovered with routine testing
Prediabetes
Impaired glucose tolerance (OGTT 140-199 mg/dL) and/or impaired fasting glucose (100-125 mg/dL), intermediate stage between normal and diabetes
Prediabetes is asymptomatic but long-term damage may already be occurring
Gestational diabetes
Develops during pregnancy, 2% to 10% in US, increases risk for complications, screens high-risk patients first visit and average-risk at 24-28 weeks, up to 63% chance of type 2 within 16 years
Other specific types of diabetes
Results from injury, interference, or destruction of beta-cell function, resolves when underlying condition is treated or drug is discontinued
Classic symptoms of type 1 diabetes
Polyuria
Polydipsia
Polyphagia
Weight loss
Weakness
Fatigue
Ketoacidosis
Nonspecific symptoms of type 2 diabetes
Fatigue
Recurrent infection
Recurrent vaginal yeast or candida infection
Prolonged wound healing
Visual problems
Diagnostic criteria for diabetes
A1C ≥6.5%, Fasting plasma glucose ≥126 mg/dL, 2-hour OGTT ≥200 mg/dL, Classic symptoms with random plasma glucose ≥200 mg/dL
A1C
Glycosylated hemoglobin that reflects glucose levels over past 2-3 months, used to diagnose, monitor, and screen for prediabetes
Drug therapy (insulin, oral agents, non-insulin injectables)
Exercise
Insulin
Exogenous (injected) insulin required for type 1 diabetes, prescribed for type 2 as disease progresses
Types of insulin
Rapid-acting
Short-acting
Intermediate-acting
Long-acting
Basal-bolus insulin regimen
Intensive or physiologic insulin therapy that most closely mimics endogenous insulin production, with bolus rapid/short-acting insulin before meals and basal intermediate/long-acting insulin once or twice daily
Human insulin
Genetically engineered in laboratories from E. coli or yeast cells
Insulins
Rapid-acting
Short-acting
Intermediate-acting
Long-acting
Insulins
They differ by onset, peak action, and duration
Basal-bolus regimen
Intensive or physiologic insulin therapy—most closely mimics endogenous insulin production
Basal-bolus regimen
1. Administer multiple daily injections (or insulin pump) with frequent self-monitoring of glucose (or continuous glucose monitoring system)
2. Bolus—rapid- or short-acting insulin before meals
3. Basal—intermediate- or long-acting (background) insulin once or twice a day
Goal of basal-bolus regimen
Glucose level as close to normal as possible as much of the time as possible